Althea Partners with UK Scientific Drug Committee to Further Education on Medicinal Cannabis and Improve Patient Access. Article Highlights: Althea collaborates…
read more
"Doctors in the dark about medicinal cannabis" A recent article published by RACGP: to read the full article click here
read moreA leading supplier of medicinal cannabis increased its Australian patient numbers by 27 per cent over a three-week period in April…
read moreAlthea now has more staff in London than Melbourne, with expectations its expertise from Australia will bring an advantage over large…
read moreAlthea is dedicated to supporting healthcare providers seeking information about and access to medicinal cannabis as a treatment option for eligible patients. One of the ways we connect with healthcare providers is by attending conferences and arranging education events.
View More Events
Our CEO Josh Fegan sat down with @CommSec's Tom Piotrowski to discuss our focus on education & technology to improve patient access to medicinal cannabis & the positive regulatory outlook for new jurisdictions & emerging markets | Video: http://ow.ly/BTEj50v0x8C
read moreAlthea is thrilled to announce that we will supply the first UK national medical cannabis pilot targeting 20,000 patients | Read the ASX announcement here: https://www.asx.com.au/asxpdf/20190625/pdf/4462xcgx974f62.pdf $AGH
read moreThe Motley Fool says "Althea Group could charge higher today" | Read why here: https://www.fool.com.au/2019/06/05/why-cannabis-company-althea-group-could-charge-higher-today/ $AGH
read more
© 2019 Althea Company Pty Ltd
